en · de · es · fr · pt
sr9009-notes.peptides6608.com › Topic › Background And Receptor Mechanism — What the Evidence Shows

Background And Receptor Mechanism — What the Evidence Shows

By Editorial Desk · published 2026-01-20 · last reviewed 2026-02-03 · Topic

Everything below concerns REV-ERB. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.

Last reviewed on 2026-02-03. Where a claim depends on a specific study, the study is described rather than over-claimed.

Background and Receptor Mechanism

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ, also called NR1D1 and NR1D2. These receptors help regulate circadian rhythms and metabolic gene programs. The compound was developed for laboratory research, not as an approved therapeutic. Its identity is distinct from steroid hormones and selective androgen receptor modulators. Scientific interest centers on how REV-ERB activation changes gene expression in cells and animal models.

At the molecular level, SR9009 binds the ligand-binding domain of REV-ERB and strengthens recruitment of corepressor proteins such as NCoR and HDAC3. This increases repression of target genes, including Bmal1 and other clock-controlled and metabolic genes. In rodent studies, such changes have been linked to altered lipid handling, glucose metabolism, and energy expenditure. The precise chain of events between receptor binding and whole-body effects remains an active area of research. Findings in animals do not automatically translate to humans.

Analytical Detection and Stability

Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.

Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.

Sr9009 at a glance

PropertyValueNotes
Chemical classSynthetic small moleculeStudied as a REV-ERB agonist
Molecular formulaC20H24ClN3O4SReported for the neutral compound
AppearanceOff-white to pale yellow solidTypical research-grade material
SolubilitySparingly soluble in waterSoluble in solvents such as DMSO
Common synonymsSR9009; StenabolicStenabolic is an informal alias

Handling Storage and Quality Control

Storage conditions for research-grade SR9009 generally involve a freezer at approximately minus twenty degrees Celsius, sometimes lower for long-term preservation. Containers should remain tightly closed and protected from light. Desiccants may be used to limit moisture uptake. Solutions are often stored in aliquots to avoid repeated warming and cooling. Stability data for the compound under various conditions are limited, so laboratories typically follow supplier recommendations and verify performance through periodic analytical checks rather than assuming indefinite stability.

Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.

Related pages on this site

Supporting material

Whitesides, "Self-assembly is the autonomous organization of components into patterns or structures without human intervention." Another definition by Serge Palacin & Renaud Demadrill is "Self-assembly is a spontaneous and reversible process that brings together in a defined geometry randomly moving distinct bodies through selective bonding forces." Importance To commemorate the 125th anniversary of Science magazine, 25 urgent questions were asked for scientists to solve, and the only one that relates to chemistry is"How Far Can We Push Chemical Self-Assembly?" Because self-assembly is the only approach for building a wide variety of nanostructures, the need for increasing complexity is growing. To learn from nature and build the nanoworld with noncovalent bonds, more research is needed in this area. Self assembly of nanomaterials is currently considered broadly for nano-structuring and nano-fabrication because of its simplicity, versatility and spontaneity. Exploiting the properties of the nano assembly holds promise as a low-cost and high-yield technique for a wide range of scientific and technological applications and is a key research effort in nanotechnology, molecular robotics, and molecular computation. A summary of benefits of self-assembly in fabrication is listed below:

== Pharmacokinetics == The metabolism of topically applied nitrofurazone is thought to be by 5-nitro reduction and cleavage of the -CH=N- linkage to generate a reactive species which can covalently bond to cellular macromolecules, none of the end products are thought to be antimicrobial.

. The preferred decay channel of those theories is p → e+ + π0. GUT theories find strong support in the convergence of the three Standard Model running coupling constants. These correspond to the fundamental interactions: α1 for the electromagnetic (hypercharge) interaction, α2 for the weak interaction, and α3 for the strong interaction. They follow renormalization group equations: α3 increases at low energies (asymptotic freedom below ~1 GeV), while α1 and α2 decrease, so that they converge, but not exactly meet, at an energy of the order of 1015 GeV, which results to be the natural energy scale of GUTs, as it is displayed in the following Figure.

Sources: en.wikipedia.org

Notes from published material

Several mutations in Rho proteins have been identified in large scale sequencing of cancers. These mutations are listed in the Catalogue of Somatic Mutations database (http://www.sanger.ac.uk/genetics/CGP/cosmic/). The functional consequences of these mutations are unknown.

The composition and destructiveness of SASP depends upon the senescent cell type, the surrounding microenvironment, and the type of stimulus inducing the senescence. Senescent cells are highly metabolically active, producing large amounts of SASP, which is why senescent cells consisting of only 2% or 3% of tissue cells can be a major cause of aging-associated diseases. SASP factors cause non-senescent cells to become senescent. SASP factors induce insulin resistance. SASP disrupts normal tissue function by producing chronic inflammation, induction of fibrosis and inhibition of stem cells. Transforming growth factor beta family members secreted by senescent cells impede differentiation of adipocytes, leading to insulin resistance. SASP factors IL-6 and TNFα enhance T-cell apoptosis, thereby impairing the capacity of the adaptive immune system. SASP factors from senescent cells reduce nicotinamide adenine dinucleotide (NAD+) in non-senescent cells, thereby reducing the capacity for DNA repair and sirtuin activity in non-senescent cells. SASP induction of the NAD+ degrading enzyme CD38 on non-senescent cells (macrophages) may be responsible for most of this effect. By contrast, NAD+ contributes to the secondary (pro-inflammatory) manifestation of SASP. Aged macrophages have a marked increase in SASP components. Bone marrow mesenchymal stem cells have a higher level of cellular senescence in older persons, resulting in a SASP-induced inflammatory environment causing disruption of factors indispensable for lymphocyte survival.

The cheek bones are strong, the incisors are large and shovel-shaped, the molars have a swollen tooth pulp (taurodontism), and there is a gap behind the molars (retromolar space). These dental traits are usually interpreted as a response to habitual heavy loading of the front teeth, either to process mechanically challenging or attritive foods, or because Neanderthals regularly used the mouth as a third hand.

=== China === In China, Pizza Hut (simplified Chinese: 必胜客; traditional Chinese: 必勝客; pinyin: Bìshèng Kè) used an altered business model, offering a fine-dining atmosphere with knives and forks and using an expanded menu catering to Chinese tastes. Its first location in the Chinese market opened in Beijing in 1990. By 2008, Pizza Hut operated restaurants and delivery locations. That year, the company introduced "Pizza Hut Express", opening locations in Shanghai, Shenzhen, and Hangzhou. The 160 restaurants were in 40 Chinese cities in 2005. As of 2015, Pizza Hut had 1,903 restaurants in China. By June 2023, there were 3,000 stores. As of the end of September 2025, Pizza Hut has over 4,000 outlets in over 1,000 cities. Savio S. Chan (陳少宏, Pinyin: Chén Shàohóng) and Michael Zakkour, authors of China's Super Consumers: What 1 Billion Customers Want and How to Sell it to Them, stated middle-class Chinese perceive Pizza Hut as "akin to fine dining", though Pizza Hut was "China's largest and most successful foreign casual-dining chain".

Sources: en.wikipedia.org

Frequently asked questions

What is SR9009?

SR9009 is a synthetic research compound that activates the REV-ERBα and REV-ERBβ nuclear receptors. It is not an approved drug and has no established human therapeutic use. Most published biological data come from cell and rodent studies.

Is SR9009 a SARM?

No. SR9009 is frequently mislabeled as a SARM in online discussions, but it does not target androgen receptors. Its known mechanism involves REV-ERB nuclear receptors and circadian-metabolic gene regulation.

What human data exist for SR9009?

Human clinical data are very limited. There is no approved human use, and safety and efficacy in people are not established. Most evidence comes from preclinical models, so effects observed in animals may not apply to humans.

How is SR9009 measured in samples?

The most common approach is liquid chromatography-tandem mass spectrometry, often after extraction from blood, urine, or tissue. Ultraviolet detection and nuclear magnetic resonance spectroscopy are used mainly for reference material characterization. Isotope-labeled internal standards improve accuracy.

Network